Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer
Jacob Taylor(The University of Texas Southwestern Medical Center), Michael A. O’Donnell(University of Iowa Health Care), Seth Lerner(Baylor College of Medicine), Elizabeth Dyer(Penn State Milton S. Hershey Medical Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Stephen Harrington(Queensland University of Technology), M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), Yair Lotan(Southwestern Medical Center), Jeffrey T. Howard(The University of Texas Southwestern Medical Center), Ian M. McElree(Vanderbilt University Medical Center), Peter C. Black(University of British Columbia), Roger Li(Unknown), Gary D. Steinberg(Rush University Medical Center), Z. Khene(Inserm), William C. Huang(NYU Langone Health), Anna J. Black(University of British Columbia), Pratik Kanabur(Carilion Clinic), Wei Shen Tan, Solomon L. Woldu(The University of Texas Southwestern Medical Center), Vignesh T. Packiam(Rutgers, The State University of New Jersey), Drupad Annapureddy(The University of Texas Southwestern Medical Center), Davaro Facundo(Moffitt Cancer Center), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Mark Preston(Brigham and Women's Hospital), Kendrick Yim(Brigham and Women's Hospital)
Cited by 19
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359